Df. Smee et al., Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice, ANTIVIR RES, 52(1), 2001, pp. 55-62
Intranasal infection of BALB/c mice with the WR strain of vaccinia virus le
ads to pneumonia, profound weight loss. and death. Although the major sites
of virus replication are in the lungs and nasal tissue, dissemination of t
he virus to other visceral organs and brain occurs via the blood. In this r
eport the effects of cidofovir on the pathogenesis of the infection was stu
died. Mice were infected intranasally with virus followed 1 day later by a
single intraperitoneal treatment with cidofovir (100 mg/kg) or placebo. Pla
cebo-treated mice were dead by day 8, whereas all cidofovir-treated animals
survived through 21 days. Cidofovir treatment did not prevent profound wei
ght loss from occurring during the acute phase of the infection, but the mi
ce gained weight quickly after the 8th day, Significantly higher arterial o
xygen saturation levels, as determined by pulse oximetry, were seen in cido
fovir-treated animals compared to placebos on days 4-7. Cidofovir treatment
markedly improved lung consolidation scores and prevented lung weights fro
m increasing during the infection. Virus titers in lungs and nasal tissue w
ere high starting from the first day of the infection, whereas the titers i
n liver, spleen, brain, and blood was low for 3 days then markedly rose bet
ween days 4 and 6. Lung and nasal virus titers were reduced 10-30-fold by c
idofovir treatment on days 2, 4 and 6. Virus titers in the other tissues an
d blood at their peak (day 6) were 30- to > 1000-fold less than in tissues
of placebos. These results illustrate the ability of a single cidofovir tre
atment to control the pathogenesis of an acute lethal infection in various
tissues during the vaccinia virus infection in mice. (C) 2001 Elsevier Scie
nce B.V. All rights reserved.